FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139253261> ?p ?o ?g. }

• W3139253261 endingPage "100070" @default.
• W3139253261 startingPage "100070" @default.
• W3139253261 abstract "Pharmacological blockade of the cannabinoid type 1 receptor, a G protein-coupled receptor expressed in the central nervous system and various peripheral tissues, reverses diet-induced obesity and dyslipidemia through the reduction of food intake and altered nutrient partitioning. This strategy is being explored for a number of therapeutic applications; however, its potency for the treatment of atherosclerotic cardiovascular disease via improvements in lipid metabolism remains unclear. Therefore, here, we aimed to investigate whether inhibition of the endocannabinoid system can attenuate atherosclerosis development through improvement of dyslipidemia. Lean, dyslipidemic female APOE∗3-Leiden.CETP transgenic mice were fed a Western-type diet supplemented with or without the cannabinoid type 1 receptor inverse agonist rimonabant (20 mg·kg body weight-1 day-1) for up to 20 weeks. Plasma lipids and bile acids were determined, and atherosclerotic lesions were scored in the aortic valve region. Rimonabant lowered plasma levels of triglyceride (TG) (-56%) and non-HDL-C (-19%) and increased HDL-C (+57%). These effects were explained by decreased VLDL-TG production (-52%) and accelerated VLDL-TG turnover accompanied by pronounced browning of white adipose tissue. In addition, rimonabant attenuated reverse cholesterol transport (-30%), increased plasma bile acid levels (+160%), and increased hepatic cholesterol accumulation (+88%). Importantly, rimonabant markedly lowered atherosclerotic lesion size (-64%), which coincided with decreased lesion severity (28% vs. 56% severe lesions) and which strongly correlated with non-HDL-C exposure (R2 = 0.60). Taken together, inhibition of the endocannabinoid system potently reverses dyslipidemia and prevents atherogenesis, even in the absence of obesity." @default.
• W3139253261 created "2021-03-29" @default.
• W3139253261 creator A5026554824 @default.
• W3139253261 creator A5029380450 @default.
• W3139253261 creator A5035385427 @default.
• W3139253261 creator A5035787663 @default.
• W3139253261 creator A5042348141 @default.
• W3139253261 creator A5042533031 @default.
• W3139253261 creator A5054260296 @default.
• W3139253261 creator A5060120678 @default.
• W3139253261 creator A5066586472 @default.
• W3139253261 creator A5080974935 @default.
• W3139253261 creator A5090780897 @default.
• W3139253261 date "2021-01-01" @default.
• W3139253261 modified "2023-09-27" @default.
• W3139253261 title "Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice" @default.
• W3139253261 cites W1972570240 @default.
• W3139253261 cites W2005456200 @default.
• W3139253261 cites W2017549783 @default.
• W3139253261 cites W2031828723 @default.
• W3139253261 cites W2032149290 @default.
• W3139253261 cites W2032823124 @default.
• W3139253261 cites W2050226999 @default.
• W3139253261 cites W2052101688 @default.
• W3139253261 cites W2056993290 @default.
• W3139253261 cites W2073208648 @default.
• W3139253261 cites W2087577664 @default.
• W3139253261 cites W2087587748 @default.
• W3139253261 cites W2089056164 @default.
• W3139253261 cites W2104652079 @default.
• W3139253261 cites W2106684644 @default.
• W3139253261 cites W2124091270 @default.
• W3139253261 cites W2132328792 @default.
• W3139253261 cites W2132358997 @default.
• W3139253261 cites W2132607058 @default.
• W3139253261 cites W2136040666 @default.
• W3139253261 cites W2136521846 @default.
• W3139253261 cites W2143941489 @default.
• W3139253261 cites W2156487253 @default.
• W3139253261 cites W2166648967 @default.
• W3139253261 cites W2230957038 @default.
• W3139253261 cites W2297240663 @default.
• W3139253261 cites W2300552860 @default.
• W3139253261 cites W2318465668 @default.
• W3139253261 cites W2467168982 @default.
• W3139253261 cites W2467925845 @default.
• W3139253261 cites W2560532666 @default.
• W3139253261 cites W2606498025 @default.
• W3139253261 cites W2625485505 @default.
• W3139253261 cites W2762951963 @default.
• W3139253261 cites W2791825490 @default.
• W3139253261 cites W2792614857 @default.
• W3139253261 cites W2908582841 @default.
• W3139253261 cites W2980188004 @default.
• W3139253261 cites W3000725886 @default.
• W3139253261 cites W3006116566 @default.
• W3139253261 doi "https://doi.org/10.1016/j.jlr.2021.100070" @default.
• W3139253261 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8082266" @default.
• W3139253261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33766515" @default.
• W3139253261 hasPublicationYear "2021" @default.
• W3139253261 type Work @default.
• W3139253261 sameAs 3139253261 @default.
• W3139253261 citedByCount "7" @default.
• W3139253261 countsByYear W31392532612021 @default.
• W3139253261 countsByYear W31392532612022 @default.
• W3139253261 countsByYear W31392532612023 @default.
• W3139253261 crossrefType "journal-article" @default.
• W3139253261 hasAuthorship W3139253261A5026554824 @default.
• W3139253261 hasAuthorship W3139253261A5029380450 @default.
• W3139253261 hasAuthorship W3139253261A5035385427 @default.
• W3139253261 hasAuthorship W3139253261A5035787663 @default.
• W3139253261 hasAuthorship W3139253261A5042348141 @default.
• W3139253261 hasAuthorship W3139253261A5042533031 @default.
• W3139253261 hasAuthorship W3139253261A5054260296 @default.
• W3139253261 hasAuthorship W3139253261A5060120678 @default.
• W3139253261 hasAuthorship W3139253261A5066586472 @default.
• W3139253261 hasAuthorship W3139253261A5080974935 @default.
• W3139253261 hasAuthorship W3139253261A5090780897 @default.
• W3139253261 hasBestOaLocation W31392532611 @default.
• W3139253261 hasConcept C126322002 @default.
• W3139253261 hasConcept C134018914 @default.
• W3139253261 hasConcept C148001335 @default.
• W3139253261 hasConcept C170493617 @default.
• W3139253261 hasConcept C185592680 @default.
• W3139253261 hasConcept C2776433454 @default.
• W3139253261 hasConcept C2778096610 @default.
• W3139253261 hasConcept C2778163477 @default.
• W3139253261 hasConcept C2778938600 @default.
• W3139253261 hasConcept C2779134260 @default.
• W3139253261 hasConcept C2780072125 @default.
• W3139253261 hasConcept C43554185 @default.
• W3139253261 hasConcept C511355011 @default.
• W3139253261 hasConcept C57089818 @default.
• W3139253261 hasConcept C71924100 @default.
• W3139253261 hasConceptScore W3139253261C126322002 @default.
• W3139253261 hasConceptScore W3139253261C134018914 @default.
• W3139253261 hasConceptScore W3139253261C148001335 @default.
• W3139253261 hasConceptScore W3139253261C170493617 @default.

• next